Nuveen
PLSE icon

Nuveen’s Pulse Biosciences PLSE Stock Holding History

Nuveen’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.82M Buy
101,683
+56,248
+124% +$1.33M ﹤0.01% 2404
2026
Q1 		$981K Sell
45,435
-2,750
-6% -$50.8K ﹤0.01% 2587
2025
Q4 		$662K Hold
48,185
– – ﹤0.01% 2775
2025
Q3 		$853K Hold
48,185
– – ﹤0.01% 2695
2025
Q2 		$727K Sell
48,185
-8,661
-15% -$144K ﹤0.01% 2751
2025
Q1 		$915K Hold
56,846
– – ﹤0.01% 2674
2024
Q4 		$990K Sell
56,846
-58,276
-51% -$1.03M ﹤0.01% 2717
2024
Q3 		$2.02M Buy
115,122
+54,786
+91% +$934K ﹤0.01% 2405
2024
Q2 		$675K Buy
60,336
+33,964
+129% +$320K ﹤0.01% 2891
2024
Q1 		$230K Hold
26,372
– – ﹤0.01% 3157
2023
Q4 		$323K Buy
26,372
+3,607
+16% +$25K ﹤0.01% 3132
2023
Q3 		$91.7K Sell
22,765
-3,788
-14% -$23.5K ﹤0.01% 3131
2023
Q2 		$191K Buy
+26,553
New +$170K ﹤0.01% 3099
2022
Q2 		– Sell
-36,567
Closed -$186K – 3437
2022
Q1 		$186K Hold
36,567
– – ﹤0.01% 3202
2021
Q4 		$598K Hold
36,567
– – ﹤0.01% 3023
2021
Q3 		$836K Sell
36,567
-4,563
-11% -$98.2K ﹤0.01% 3053
2021
Q2 		$675K Sell
41,130
-11,844
-22% -$225K ﹤0.01% 3123
2021
Q1 		$1.25M Sell
52,974
-8,737
-14% -$261K ﹤0.01% 2816
2020
Q4 		$1.47M Sell
61,711
-5,620
-8% -$89.4K ﹤0.01% 2656
2020
Q3 		$793K Buy
67,331
+331
+0.5% +$3.56K ﹤0.01% 2786
2020
Q2 		$701K Buy
67,000
+26,605
+66% +$240K ﹤0.01% 2772
2020
Q1 		$289K Sell
40,395
-215
-0.5% -$2.23K ﹤0.01% 2933
2019
Q4 		$544K Hold
40,610
– – ﹤0.01% 2890
2019
Q3 		$627K Sell
40,610
-2,164
-5% -$28.1K ﹤0.01% 2877
2019
Q2 		$564K Buy
+42,774
New +$584K ﹤0.01% 2966

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Nuveen's PLSE Position: Q2 2026 in Review

Nuveen increased its Pulse Biosciences (PLSE) stake by 124% in Q2 2026, buying an estimated $1.33M and bringing the position to 101,683 shares worth $2.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2404.

Nuveen first reported a position in PLSE in Q2 2019 and has held it in 25 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Nuveen held 101,683 shares of Pulse Biosciences worth $2.82M as of Q2 2026.
  • Nuveen bought 56,248 Pulse Biosciences shares in Q2 2026, an estimated $1.33M.
  • Pulse Biosciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2404 holding.
  • Nuveen first reported a position in Pulse Biosciences in Q2 2019 and has held it in 25 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.